Key points are not available for this paper at this time.
Mitotic inhibition following treatment with eribulin and copanlisib by IHC in 3 eribulin-resistant PDX models
Share your take
Add a clinician perspective alongside expert commentary.
Guo et al. (Wed,) studied this question.